FDG positron emission tomography in head and neck cancer.
D054598:Blue Cross Blue Shield Insurance Plans; D002986:Clinical Trials as Topic; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging*; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D017063:Outcome Assessment, Health Care; D011859:Radiography; D019275:Radiopharmaceuticals; D013673:Technology Assessment, Biomedical; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18